-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pharmagreen Biotech Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q1 2023.
- Pharmagreen Biotech Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$188K, a 81.9% increase year-over-year.
- Pharmagreen Biotech Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$231K, a 86.8% increase year-over-year.
- Pharmagreen Biotech Inc. annual Operating Income (Loss) for 2022 was -$1.1M, a 48% decline from 2021.
- Pharmagreen Biotech Inc. annual Operating Income (Loss) for 2021 was -$744K, a 53.2% decline from 2020.
- Pharmagreen Biotech Inc. annual Operating Income (Loss) for 2020 was -$486K, a 24.4% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)